Amantadine

CAT:
804-HY-B0402
Size:
500 mg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Amantadine
UNSPSC Description:
Amantadine (1-Adamantanamine) is an orally avtive and potent antiviral agent with activity against influenza A viruses. Amantadine inhibits several ion channels such as NMDA and M2, and also inhibits Coronavirus ion channels. Amantadine also has anti-orthopoxvirus and anticancer activity. Amantadine can be used for Parkinson's disease, postoperative cognitive dysfunction (POCD) and COVID-19 research[1][2][3][4][5][6].Target Antigen:
Apoptosis; Bcl-2 Family; CDK; Influenza Virus; Orthopoxvirus; SARS-CoVType:
Reference compoundRelated Pathways:
Anti-infection;Apoptosis;Cell Cycle/DNA DamageApplications:
COVID-19-anti-virusField of Research:
Cancer; Infection; Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/amantadine.htmlPurity:
99.90Solubility:
DMSO : 6.48 mg/mL (ultrasonic;warming;adjust pH to 4 with 1 M HCL;heat to 60°C)Smiles:
NC12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3Molecular Weight:
151.253References & Citations:
[1]Suzuki H, et al. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother. 2003;9(3):195-200.|[2]Hubsher G, et al. Amantadine: the journey from fighting flu to treating Parkinson disease. Neurology. 2012;78(14):1096-1099.|[3]Donald F Smee, et al. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 2003 Jan;57(1-2):41-52. |[4]Fink K, et al. Amantadine Inhibits SARS-CoV-2 In Vitro. Viruses. 2021 Mar 24;13(4):539. |[5]Zhang J, et al. Amantadine alleviates postoperative cognitive dysfunction possibly by increasing glial cell line-derived neurotrophic factor in rats. Anesthesiology. 2014 Oct;121(4):773-85.|[6]Lan Z, et al. Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro. Int J Mol Med. 2015;36(3):904-910.SSRN. 2024 Aug 7.|Chem Phys Lipids. 2024 May 11:262:105397.|Int J Nanomedicine. 2019 Nov 27;14:9217-9234.|Signal Transduct Target Ther. 2021 Mar 27;6(1):134.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, protect from light)Clinical Information:
LaunchedCAS Number:
768-94-5
